# Passage Bio (PASG) — Earnings

PASG · NASDAQ · Stock

Canonical page: https://www.lighthorse.io/tickers/pasg/earnings

## Most recent quarter

| Metric | Value |
| --- | --- |
| Fiscal period | Q3 2025 |
| Period end | Sep 30, 2025 |
| EPS actual | −$2.44 |
| EPS estimate | −$2.76 |
| EPS surprise | +11.51% |
| Revenue surprise | +0.00% |
| Revenue | $0.00 |
| Revenue estimate | $0.00 |
| Reported | Nov 10, 2025 |
| SEC filing | [View filing](https://www.sec.gov:443/Archives/edgar/data/1787297/000110465925109180/pasg-20250930x10q.htm) |

## Earnings history

| Fiscal period | Report date | EPS estimate | EPS actual | Surprise | Revenue estimate | Revenue actual |
| --- | --- | --- | --- | --- | --- | --- |
| Q3 2025 | Nov 10, 2025 | −$2.76 | −$2.44 | 11.51% | — | — |
| Q2 2025 | Aug 12, 2025 | −$4.04 | −$2.96 | 26.73% | — | — |
| Q1 2025 | May 13, 2025 | −$4.60 | −$5.00 | -8.70% | — | — |
| Q4 2024 | Mar 4, 2025 | −$4.30 | −$4.00 | 6.98% | — | — |
| Q3 2024 | Nov 13, 2024 | −$4.64 | −$6.20 | -33.74% | $1.7M | — |
| Q2 2024 | Aug 8, 2024 | −$6.18 | −$5.20 | 15.92% | — | — |
| Q1 2024 | May 14, 2024 | −$7.15 | −$6.00 | 16.08% | — | — |
| Q4 2023 | Mar 4, 2024 | −$7.72 | −$6.00 | 22.28% | — | — |
| Q3 2023 | Nov 13, 2023 | −$9.13 | −$9.80 | -7.30% | — | — |
| Q2 2023 | Aug 7, 2023 | −$9.47 | −$8.80 | 7.04% | — | — |
| Q1 2023 | May 11, 2023 | −$10.78 | −$12.60 | -16.87% | — | — |
| Q4 2022 | Mar 6, 2023 | −$10.46 | −$10.00 | 4.39% | — | — |
| Q3 2022 | Nov 10, 2022 | −$15.54 | −$9.80 | 36.96% | — | — |
| Q2 2022 | Aug 4, 2022 | −$16.62 | −$14.60 | 12.16% | — | — |
| Q1 2022 | May 16, 2022 | −$17.75 | −$15.80 | 11.00% | — | — |
| Q4 2021 | Mar 3, 2022 | −$17.44 | −$19.00 | -8.95% | — | — |
| Q3 2021 | Nov 4, 2021 | −$16.86 | −$17.40 | -3.22% | — | — |
| Q2 2021 | Aug 5, 2021 | −$14.69 | −$18.00 | -22.57% | — | — |
| Q1 2021 | May 5, 2021 | −$14.65 | −$15.20 | -3.74% | — | — |
| Q4 2020 | Mar 3, 2021 | −$13.77 | −$17.00 | -23.47% | — | — |

## Frequently Asked Questions

### When did Passage Bio (PASG) last report earnings?

Passage Bio last reported on Nov 10, 2025, covering fiscal Q3 2025.

### Did PASG beat earnings estimates?

Yes. Passage Bio reported EPS of −$2.44 for Q3 2025 against a −$2.76 estimate — a 11.51% beat.

---

Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.

This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.

Data provided by [AInvest](https://www.ainvest.com).